Analyst Price Targets — AGEN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 29, 2024 11:34 am | Emily Bodnar | H.C. Wainwright | $7.00 | $3.57 | StreetInsider | H.C. Wainwright Reiterates Neutral Rating on Agenus Inc. (AGEN) |
| July 19, 2024 8:55 am | Biren Amin | Jefferies | $7.00 | $5.99 | StreetInsider | Jefferies Downgrades Agenus Inc. (AGEN) to Hold |
| July 19, 2024 4:59 am | Colleen Kusy | Robert W. Baird | $8.00 | $7.30 | TheFly | Agenus downgraded to Neutral from Outperform at Baird |
| July 18, 2024 12:33 pm | Emily Bodnar | H.C. Wainwright | $9.00 | $7.98 | TheFly | Agenus downgraded to Neutral from Buy at H.C. Wainwright |
| July 1, 2024 6:42 am | Emily Bodnar | H.C. Wainwright | $20.00 | $8.38 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Agenus Inc. (AGEN) |
Latest News for AGEN
TECH gears up for Q3 results with modest revenue growth expected as biotech funding trends and product momentum shape the outlook.
VRTX heads into Q1 earnings with Trikafta demand, rising Alyftrek sales, and Casgevy and Journavx sales in focus ahead of the May 4 report.
HSIC heads into Q1 earnings results with steady estimates, a 5.1% revenue growth outlook and strength across distribution, specialty products and tech.
CI approaches Q1 results with strong pharmacy growth but a steep premium drop, as estimates point to mixed year-over-year performance.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AGEN.
U.S. House Trading
No House trades found for AGEN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.